No­vavax CFO Greg Covi­no makes a quick ex­it as lead­er­ship carousel keeps turn­ing; Kite ex­ecs fly away to a cell ...

5 years ago
Peer Review

Look­ing to ce­ment its lead in packed MS mar­ket, Roche's Ocre­vus un­corks new da­ta in ear­ly-stage pa­tients

5 years ago
R&D

J&J faces CDC ad­vi­so­ry com­mit­tee again next week to weigh Covid-19 vac­cine risks

5 years ago
Coronavirus

Opin­ion: Pfiz­er, BioN­Tech did­n't take US gov­ern­men­t's sup­port to de­vel­op their vac­cine. Let's stop rewrit­ing the ...

5 years ago
Opinion

In high­ly un­usu­al move, Paci­ra sues med­ical jour­nal for li­bel over its non-opi­oid painkiller

5 years ago
Pharma

Covid-19 roundup: Biden in­vests $1.7B to ad­dress Covid vari­ants; EU puts faith in Pfiz­er with new vac­cine deals

5 years ago
Coronavirus

Os­man Kibar lays down his hand at Sa­mumed, step­ping away from CEO role as his once-her­ald­ed an­ti-ag­ing biotech ...

5 years ago
Financing

In one of their first ever ac­qui­si­tions, Re­lay bets $85M cash on a new AI-based screen­ing ap­proach

5 years ago
Deals

Eli Lil­ly-part­nered biotech taps star in­ves­ti­ga­tor Alan List as CMO — a year af­ter he re­signed from Mof­fitt over ...

5 years ago
People

FDA re­vokes EUA for Eli Lil­ly Covid-19 treat­ment

5 years ago
FDA+
Coronavirus

Abzena picks North Car­oli­na as the home for its 6th man­u­fac­tur­ing site, plans to add 325 jobs in San­ford

5 years ago
Outsourcing
Manufacturing

Avro­bio is us­ing 'pod­s' to cre­ate gene ther­a­pies, and it be­lieves the ap­proach could change the game al­to­geth­er

5 years ago
R&D
Manufacturing

FDA blasts Colom­bian drug man­u­fac­tur­er in warn­ing let­ter for not prop­er­ly ad­dress­ing API flaws

5 years ago
R&D
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Mod­er­na eyes Nexus' Wis­con­sin plant for vac­cine boost; Catal­ent wraps up plant ...

5 years ago
Coronavirus
Manufacturing

Ex­clu­sive: Vik Ba­jaj set out al­most 2 years ago to hatch new com­pa­nies that would shake up health­care with da­ta ...

5 years ago
Startups

Alchemab bags fresh round of in­vestors for tar­get-ag­nos­tic an­ti­body de­vel­op­ment for Hunt­ing­ton's, Covid-19

5 years ago
Financing
R&D

The world of Wnt heads to Nas­daq as Sur­rozen an­nounces a $212M SPAC deal

5 years ago
Financing

Roche touts 2-year ef­fi­ca­cy da­ta for SMA ther­a­py Evrys­di; NIH funds new net­work to study flu and virus­es with ...

5 years ago
News Briefing

PDU­FA VII to ex­pand FDA’s re­al-time on­col­o­gy re­views to sup­ple­ments for all ther­a­peu­tic ar­eas

5 years ago
FDA+

Ac­tivist in­vestor grabs a multi­bil­lion-pound stake in Glax­o­SmithK­line, trig­ger­ing buzz about a loom­ing show­down at ...

5 years ago
Bioregnum
R&D

Af­ter a ma­jor facelift, Al­tru­Bio says it's ready for a piv­otal fight against graft-ver­sus-host dis­ease

5 years ago
Financing

Glax­o­SmithK­line’s head of vac­cine R&D is jump­ing to a well­ness com­pa­ny con­cen­trat­ing on the mi­cro­bio­me as re­ports ...

5 years ago
People

Mer­ck scraps their $425M Covid-19 drug in lat­est pan­dem­ic set­back

5 years ago
R&D
Coronavirus

Eli Lil­ly ax­es 163 Der­mi­ra staffers, shut­ters Men­lo Park site as it clos­es in around Dupix­ent ri­val le­brik­izum­ab

5 years ago
People
Pharma
First page Previous page 716717718719720721722 Next page Last page
A service from the Financial Times